At Emerald Health Pharmaceuticals (EHP), we are focused on the development of a new class of drugs with precise mechanisms of action aimed at bringing innovative therapies to patients to treat diseases with significant unmet medical needs.
We believe our novel patented molecules have the potential to be developed into safe and effective pharmaceutical compounds to treat a wide range of diseases, such as neurodegenerative, auto-immune, inflammatory, fibrotic, cardiovascular, and metabolic diseases.
Meet the team
Our proprietary drug candidates continue to advance through the development process for various medical indications.
Our unique molecules have been rationally designed to address specific biological targets and physiological pathways validated as key targets in a wide range of diseases.
Emerald Health Pharmaceuticals continues to establish relationships with industry leaders to further advance company research and product development.
Cannabinoid science centered around patient outcomes